InsiderTrades

Form 4 for IDXX Idexx Laboratories

Accepted 2021-08-09 00:00:00 ET · period of report 2021-08-05 · accession 0001567619-21-014768 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2021-08-09 2021-08-05 IDXX Hunt Nimrata EVP M - OptEx $137.90 +538 8,644 +7% +$74.2K
D 2021-08-09 2021-08-05 IDXX Hunt Nimrata EVP S - Sale+OE $703.00 -538 8,106 -6% -$378.2K
DM 2021-08-09 2021-08-05 IDXX Hunt Nimrata EVP M - OptEx — -538 1,218 -31% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-08-05 M A 27 $67.85 8,133.28 D — — (F1) Includes a total of 23.2845 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 31, 2021 and June 30, 2021.
2 Common Common Stock 2021-08-05 M A 511 $141.60 8,644.28 D — —
3 Common Common Stock 2021-08-05 S D 538 $703.00 8,106.28 D — —
4 Derivative Non-Qualified Stock Option (right-to-buy) 2021-08-05 M D 27 — 0 D $67.85 · — to 2026-02-13 27 Common Stock (F4) Not applicable. (F2) Grant of option to buy 1,940 shares of Issuer common stock that vested in five annual installments beginning on February 14, 2017.
5 Derivative Non-Qualified Stock Option (right-to-buy) 2021-08-05 M D 511 — 1,218 D $141.60 · — to 2027-02-13 511 Common Stock (F4) Not applicable. (F3) Grant of option to buy 3,579 shares of Issuer common stock that vest in five annual installments beginning on February 14, 2018.